A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration

by | Jun 17, 2025 | Clinical Trials | 0 comments

​ Conditions: Dry Age Related Macular Degeneration

Interventions: Biological: PST-611

Sponsors: Eyevensys

Not yet recruiting Conditions: Dry Age Related Macular Degeneration
Interventions: Biological: PST-611
Sponsors: Eyevensys
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *